Cel
This research addresses a clinical problem with an innovative approach. Pancreatic cancer is one of the deadliest cancers and only 10% of patients survive 5 years after diagnosis. To find better therapies, we need patient-specific models that mimic the biology of tumour tissues and target interactions between different cell types. We will develop a controllable platform for modelling the human disease in the laboratory. We will use our new platform to discover better ways of treating the disease.
Słowa kluczowe
Program(-y)
- HORIZON.1.1 - European Research Council (ERC) Main Programme
System finansowania
HORIZON-ERC-POC - HORIZON ERC Proof of Concept GrantsInstytucja przyjmująca
LEIBNIZ-INSTITUT FUR POLYMERFORSCHUNG DRESDEN EV
Wkład UE netto
€ 150 000,00
Adres
HOHE STRASSE 6
01069 Dresden
Niemcy
01069 Dresden
Niemcy
Region
Sachsen
Dresden
Dresden, Kreisfreie Stadt
Rodzaj działalności
Research Organisations
Linki
Koszt całkowity
Brak danych